Table of Contents

May 01 1999; volume 22 issue 5

You have accessRestricted Access
Is glucose a continuous risk factor for cardiovascular mortality?
H C Gerstein

Diabetes Care 1999 May; 22 (5): 659-660. https://doi.org/10.2337/diacare.22.5.659
You have accessRestricted Access
What do internal medicine residents need to enhance their diabetes care?
A M Bernard, L Anderson, C B Cook and L S Phillips

Diabetes Care 1999 May; 22 (5): 661-666. https://doi.org/10.2337/diacare.22.5.661
You have accessRestricted Access
Effects of meal carbohydrate content on insulin requirements in type 1 diabetic patients treated intensively with the basal-bolus (ultralente-regular) insulin regimen.
R Rabasa-Lhoret, J Garon, H Langelier, D Poisson and J L Chiasson

Diabetes Care 1999 May; 22 (5): 667-673. https://doi.org/10.2337/diacare.22.5.667
You have accessRestricted Access
Therapy of severe diabetic ketoacidosis. Zero-mortality under very-low-dose insulin application.
A Wagner, A Risse, H L Brill, V Wienhausen-Wilke, M Rottmann, K Sondern and B Angelkort

Diabetes Care 1999 May; 22 (5): 674-677. https://doi.org/10.2337/diacare.22.5.674
You have accessRestricted Access
Amputation prevention by vascular surgery and podiatry collaboration in high-risk diabetic and nondiabetic patients. The Operation Desert Foot experience.
C C Van Gils, L A Wheeler, M Mellstrom, E A Brinton, S Mason and C G Wheeler

Diabetes Care 1999 May; 22 (5): 678-683. https://doi.org/10.2337/diacare.22.5.678
You have accessRestricted Access
Effects of aerobic or resistance exercise and/or diet on glucose tolerance and plasma insulin levels in obese men.
B Rice, I Janssen, R Hudson and R Ross

Diabetes Care 1999 May; 22 (5): 684-691. https://doi.org/10.2337/diacare.22.5.684
You have accessRestricted Access
Healing of diabetic neuropathic foot ulcers receiving standard treatment. A meta-analysis.
D J Margolis, J Kantor and J A Berlin

Diabetes Care 1999 May; 22 (5): 692-695. https://doi.org/10.2337/diacare.22.5.692
You have accessRestricted Access
Is there a glycemic threshold for mortality risk?
B Balkau, S Bertrais, P Ducimetiere and E Eschwege

Diabetes Care 1999 May; 22 (5): 696-699. https://doi.org/10.2337/diacare.22.5.696
You have accessRestricted Access
Risk for metabolic control problems in minority youth with diabetes.
A M Delamater, K H Shaw, E B Applegate, I A Pratt, M Eidson, G X Lancelotta, L Gonzalez-Mendoza and S Richton

Diabetes Care 1999 May; 22 (5): 700-705. https://doi.org/10.2337/diacare.22.5.700
You have accessRestricted Access
Correlates of physical activity in a sample of older adults with type 2 diabetes.
L M Hays and D O Clark

Diabetes Care 1999 May; 22 (5): 706-712. https://doi.org/10.2337/diacare.22.5.706
You have accessRestricted Access
An office-based intervention to maintain parent-adolescent teamwork in diabetes management. Impact on parent involvement, family conflict, and subsequent glycemic control.
B J Anderson, J Brackett, J Ho and L M Laffel

Diabetes Care 1999 May; 22 (5): 713-721. https://doi.org/10.2337/diacare.22.5.713
You have accessRestricted Access
Latino beliefs about diabetes.
S C Weller, R D Baer, L M Pachter, R T Trotter, M Glazer, J E Garcia de Alba Garcia and R E Klein

Diabetes Care 1999 May; 22 (5): 722-728. https://doi.org/10.2337/diacare.22.5.722
You have accessRestricted Access
Impact of maternal nativity on the prevalence of diabetes during pregnancy among U.S. ethnic groups.
E C Kieffer, J A Martin and W H Herman

Diabetes Care 1999 May; 22 (5): 729-735. https://doi.org/10.2337/diacare.22.5.729
You have accessRestricted Access
Antidiabetic treatment trends in a cohort of elderly people with diabetes. The cardiovascular health study, 1989-1997.
N L Smith, S R Heckbert, V A Bittner, P J Savage, J I Barzilay, A S Dobs and B M Psaty

Diabetes Care 1999 May; 22 (5): 736-742. https://doi.org/10.2337/diacare.22.5.736
You have accessRestricted Access
The 10-year incidence of renal insufficiency in people with type 1 diabetes.
R Klein, B E Klein, S E Moss, K J Cruickshanks and P C Brazy

Diabetes Care 1999 May; 22 (5): 743-751. https://doi.org/10.2337/diacare.22.5.743
You have accessRestricted Access
Effect of multiple patient reminders in improving diabetic retinopathy screening. A randomized trial.
R J Halbert, K M Leung, J M Nichol and A P Legorreta

Diabetes Care 1999 May; 22 (5): 752-755. https://doi.org/10.2337/diacare.22.5.752
You have accessRestricted Access
Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study.
R de Marco, F Locatelli, G Zoppini, G Verlato, E Bonora and M Muggeo

Diabetes Care 1999 May; 22 (5): 756-761. https://doi.org/10.2337/diacare.22.5.756
You have accessRestricted Access
Impact of new diagnostic criteria for diabetes on different populations.
J E Shaw, M de Courten, E J Boyko and P Z Zimmet

Diabetes Care 1999 May; 22 (5): 762-766. https://doi.org/10.2337/diacare.22.5.762
You have accessRestricted Access
Factor VIII and other hemostasis variables are related to incident diabetes in adults. The Atherosclerosis Risk in Communities (ARIC) Study.
B B Duncan, M I Schmidt, S Offenbacher, K K Wu, P J Savage and G Heiss

Diabetes Care 1999 May; 22 (5): 767-772. https://doi.org/10.2337/diacare.22.5.767
You have accessRestricted Access
Incidence, prevalence, and mortality of diabetes in a large population. A report from the Skaraborg Diabetes Registry.
B Berger, G Stenström and G Sundkvist

Diabetes Care 1999 May; 22 (5): 773-778. https://doi.org/10.2337/diacare.22.5.773
You have accessRestricted Access
Black-white differences in risk of developing retinopathy among individuals with type 2 diabetes.
E L Harris, S H Sherman and A Georgopoulos

Diabetes Care 1999 May; 22 (5): 779-783. https://doi.org/10.2337/diacare.22.5.779
You have accessRestricted Access
Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Results of a multicenter trial. German Humalog-CSII Study Group.
R Renner, A Pfützner, M Trautmann, O Harzer, K Sauter and R Landgraf

Diabetes Care 1999 May; 22 (5): 784-788. https://doi.org/10.2337/diacare.22.5.784
You have accessRestricted Access
A double-blind randomized comparison of meal-related glycemic control by repaglinide and glyburide in well-controlled type 2 diabetic patients.
P Damsbo, P Clauson, T C Marbury and K Windfeld

Diabetes Care 1999 May; 22 (5): 789-794. https://doi.org/10.2337/diacare.22.5.789
You have accessRestricted Access
Contribution of postprandial versus interprandial blood glucose to HbA1c in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtime.
M Ciofetta, C Lalli, P Del Sindaco, E Torlone, S Pampanelli, L Mauro, D L Chiara, P Brunetti and G B Bolli

Diabetes Care 1999 May; 22 (5): 795-800. https://doi.org/10.2337/diacare.22.5.795
You have accessRestricted Access
Improved postprandial glycemic control with insulin aspart. A randomized double-blind cross-over trial in type 1 diabetes.
A Lindholm, J McEwen and A P Riis

Diabetes Care 1999 May; 22 (5): 801-805. https://doi.org/10.2337/diacare.22.5.801
You have accessRestricted Access
Protein metabolism in insulin-treated gestational diabetes.
N F Butte, H W Hsu, M Thotathuchery, W W Wong, J Khoury and P Reeds

Diabetes Care 1999 May; 22 (5): 806-811. https://doi.org/10.2337/diacare.22.5.806
You have accessRestricted Access
Apolipoprotein(B) identifies dyslipidemic phenotypes associated with cardiovascular risk in normocholesterolemic type 2 diabetic patients.
A M Wägner, A Pérez, F Calvo, R Bonet, A Castellví and J Ordóñez

Diabetes Care 1999 May; 22 (5): 812-817. https://doi.org/10.2337/diacare.22.5.812
You have accessRestricted Access
Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas.
M Emoto, Y Nishizawa, K Maekawa, Y Hiura, H Kanda, T Kawagishi, T Shoji, Y Okuno and H Morii

Diabetes Care 1999 May; 22 (5): 818-822. https://doi.org/10.2337/diacare.22.5.818
You have accessRestricted Access
Abnormality in urinary protein excretion in Japanese men with impaired glucose tolerance.
H Fujita, T Narita and S Ito

Diabetes Care 1999 May; 22 (5): 823-826. https://doi.org/10.2337/diacare.22.5.823
You have accessRestricted Access
Impact of peripheral neuropathy on bone density in patients with type 1 diabetes.
M Rix, H Andreassen and P Eskildsen

Diabetes Care 1999 May; 22 (5): 827-831. https://doi.org/10.2337/diacare.22.5.827
You have accessRestricted Access
Behavioral science in diabetes. Contributions and opportunities.
R E Glasgow, E B Fisher, B J Anderson, A LaGreca, D Marrero, S B Johnson, R R Rubin and D J Cox

Diabetes Care 1999 May; 22 (5): 832-843. https://doi.org/10.2337/diacare.22.5.832
You have accessRestricted Access
On the need for outcome trials in preventive pharmacology. Lessons from the recent experience with adverse drug reactions.
M P Stern

Diabetes Care 1999 May; 22 (5): 844-845. https://doi.org/10.2337/diacare.22.5.844
You have accessRestricted Access
Retinopathy risk: what is responsible? Hormones, hyperglycemia, or humalog? Response to Kitzmiller et al.
L Jovanovic

Diabetes Care 1999 May; 22 (5): 846-848. https://doi.org/10.2337/diacare.22.5.846
You have accessRestricted Access
Genes and the cell biology of insulin secretion and insulin resistance.
Z T Bloomgarden

Diabetes Care 1999 May; 22 (5): 849-853. https://doi.org/10.2337/diacare.22.5.849
You have accessRestricted Access
Metformin added to insulin therapy in poorly controlled type 2 diabetes.
I B Hirsch

Diabetes Care 1999 May; 22 (5): 854. https://doi.org/10.2337/diacare.22.5.854b
You have accessRestricted Access
Reliability of blood glucose self-monitoring and its influence on glycemic control in highly motivated type 1 diabetic patients.
P Ladyzyński, J M Wójcicki, E Jóźwicka, J Blachowicz and J Krzymień

Diabetes Care 1999 May; 22 (5): 854-856. https://doi.org/10.2337/diacare.22.5.854a
You have accessRestricted Access
Coronary heart disease in women with diabetes. Positive association with past hysterectomy and possible benefits of hormone replacement therapy.
R A Lawrenson, G M Leydon, R B Newson and M D Feher

Diabetes Care 1999 May; 22 (5): 856-857. https://doi.org/10.2337/diacare.22.5.856
You have accessRestricted Access
Orthodeoxia-platypnea due to diabetic autonomic neuropathy.
T G Ferry and C C Naum

Diabetes Care 1999 May; 22 (5): 857-859. https://doi.org/10.2337/diacare.22.5.857
You have accessRestricted Access
Metformin and lipoprotein(a) levels.
J A Kiayias, E D Vlachou and E L Papadodima

Diabetes Care 1999 May; 22 (5): 859. https://doi.org/10.2337/diacare.22.5.859b
You have accessRestricted Access
Troglitazone's effect on lipoprotein(a) levels.
F Ovalle and D S Bell

Diabetes Care 1999 May; 22 (5): 859-860. https://doi.org/10.2337/diacare.22.5.859a
You have accessRestricted Access
An interaction between digoxin and acarbose.
H Ben-Ami, N Krivoy, P Nagachandran, A Roguin and Y Edoute

Diabetes Care 1999 May; 22 (5): 860-861. https://doi.org/10.2337/diacare.22.5.860
You have accessRestricted Access
Hypoglycemic urticaria revisited.
A S Sacerdote

Diabetes Care 1999 May; 22 (5): 861. https://doi.org/10.2337/diacare.22.5.861b
You have accessRestricted Access
Increased nitric oxide levels in aqueous humor of diabetic patients with neovascular glaucoma.
S H Chiou, C J Chang, C K Chou, W M Hsu, J H Liu and C H Chiang

Diabetes Care 1999 May; 22 (5): 861-862. https://doi.org/10.2337/diacare.22.5.861a
You have accessRestricted Access
Hypoglycemia associated with maprotiline in a patient with type 1 diabetes.
H Isotani and K Kameoka

Diabetes Care 1999 May; 22 (5): 862-863. https://doi.org/10.2337/diacare.22.5.862
You have accessRestricted Access
Renal tubular function affects glycosuria-related urinary excretion of 1,5-anhydroglucitol.
T Fujisawa, H Ikegami, T Tsutsui, Y Kawaguchi, H Ueda, M Shintani, K Nojima, Y Kawabata, M Ono, M Nishino, S Noso, K Yamada, N Babaya and T Ogihara

Diabetes Care 1999 May; 22 (5): 863-864. https://doi.org/10.2337/diacare.22.5.863
You have accessRestricted Access
Plasma magnesium concentration and progression of retinopathy.
H W de Valk, P L Hardus, H J van Rijn and D W Erkelens

Diabetes Care 1999 May; 22 (5): 864-865. https://doi.org/10.2337/diacare.22.5.864
You have accessRestricted Access
Premixed formulations of insulin lispro. Activity profiles in type 1 diabetic patients.
K Rave, L Heinemann, L Puhl, U Gudat, J R Woodworth, C Weyer and T Heise

Diabetes Care 1999 May; 22 (5): 865-866. https://doi.org/10.2337/diacare.22.5.865
You have accessRestricted Access
Durable reversal of hypoglycemia unawareness in type 1 diabetes.
S Dagogo-Jack, C G Fanelli and P E Cryer

Diabetes Care 1999 May; 22 (5): 866-867. https://doi.org/10.2337/diacare.22.5.866
You have accessRestricted Access
A case of hepatocyte nuclear factor-1 alpha diabetes/MODY3 masquerading as type 1 diabetes in a Mexican-American adolescent and responsive to a low dose of sulfonylurea.
E H Hathout, B N Cockburn, J W Mace, J Sharkey, J Chen-Daniel and G I Bell

Diabetes Care 1999 May; 22 (5): 867-868. https://doi.org/10.2337/diacare.22.5.867
You have accessRestricted Access
Insulin response to intravenous glucose correlates with plasma levels of the tumor necrosis factor receptor-1.
J M Fernández-Real, C Gutiérrez, M Broch, R Casamitjana, J Vendrell and W Ricart

Diabetes Care 1999 May; 22 (5): 868-870. https://doi.org/10.2337/diacare.22.5.868
You have accessRestricted Access
Oxidative stress and antioxidant supplementation in type I diabetes.
F Granado Lorencio and B Olmedilla Alonso

Diabetes Care 1999 May; 22 (5): 870-873. https://doi.org/10.2337/diacare.22.5.870
You have accessRestricted Access
Of gestational diabetes, finesse, and an antipodean snark.
R Davey

Diabetes Care 1999 May; 22 (5): 873-874. https://doi.org/10.2337/diacare.22.5.873
You have accessRestricted Access
Insulin lispro and the development of proliferative diabetic retinopathy during pregnancy.
J L Kitzmiller, E Main, B Ward, T Theiss and D L Peterson

Diabetes Care 1999 May; 22 (5): 874-876. https://doi.org/10.2337/diacare.22.5.874
You have accessRestricted Access
Association between central adiposity and multimetabolic syndrome in a special cohort of women with prior gestational diabetes.
Z Kerényi, P Stella, Z Bosnyák, A G Tabák and G Tamás

Diabetes Care 1999 May; 22 (5): 876-877. https://doi.org/10.2337/diacare.22.5.876
You have accessRestricted Access
Increased serum levels of pentosidine, but not carboxymethyl lysine, in type 2 diabetes without obvious diabetic nephropathy.
M Daimon, Y Ono, T Saito, H Yamaguchi, A Hirata, H Ohnuma, M Igarashi, H Eguchi, H Manaka and T Kato

Diabetes Care 1999 May; 22 (5): 877-878. https://doi.org/10.2337/diacare.22.5.877